DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193.
N Hajji, N Pastor, S Mateos, I Domínguez, F Cortés
Index: Mutat. Res. 530 , 35-46, (2003)
Full Text: HTML
Abstract
The bis-dioxopiperazine ICRF-193 has long time been considered as a pure topoisomerase II catalytic inhibitor able to exert its inhibitory effect on the enzyme without stabilization of the so-called cleavable complex formed by DNA covalently bound to topoisomerase II. In recent years, however, this concept has been challenged, as a number of reports have shown that ICRF-193 really "poisons" the enzyme, most likely through a different mechanism from that shown by the classical topoisomerase II poisons used in cancer chemotherapy. In the present investigation, we have carried out a study of the capacity of ICRF-193 to induce DNA strand breaks, as classical poisons do, in cultured V79 and irs-2 Chinese hamster lung fibroblasts using the comet assay and pulsed-field gel electrophoresis (PFGE). Our results clearly show that ICRF-193 readily induces breakage in DNA through a mechanism as yet poorly understood.
Related Compounds
Related Articles:
Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs.
1999-05-15
[Biochem. Pharmacol. 57 , 1105, (1999)]
Topoisomerase II poisoning by ICRF-193.
2001-11-30
[J. Biol. Chem. 276 , 44488-44494, (2001)]
ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
2002-09-27
[J. Biol. Chem. 277 , 36832, (2002)]
2001-03-01
[Mol. Pharmacol. 59 , 453, (2001)]